OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 and autoimmune bullous diseases: Lessons learned
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Michael Kasperkiewicz, David T. Woodley
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103286-103286
Open Access | Times Cited: 6
Showing 6 citing articles:
Cocamidopropyl Betaine: Another Possible Oral Healthcare Chemical Associated with Plasma Cell Lesions of The Oral Cavity
Jay Saepoo, Nidhi Handoo, Sherry Timmons, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025)
Closed Access
Jay Saepoo, Nidhi Handoo, Sherry Timmons, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025)
Closed Access
The impact of the mRNA COVID-19 vaccine on the Th-like cytokine profile in individuals with no history of COVID-19: insights into autoimmunity targeting heat shock proteins
Stefan Tukaj, Magdalena Sitna, Krzysztof Sitko
Frontiers in Immunology (2025) Vol. 16
Open Access
Stefan Tukaj, Magdalena Sitna, Krzysztof Sitko
Frontiers in Immunology (2025) Vol. 16
Open Access
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge
Mohammad Darkhabani, Mohamad Aosama Alrifaai, Abdulrahman Elsalti, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 8, pp. 103360-103360
Closed Access | Times Cited: 14
Mohammad Darkhabani, Mohamad Aosama Alrifaai, Abdulrahman Elsalti, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 8, pp. 103360-103360
Closed Access | Times Cited: 14
Rituximab treatment for refractory and moderate-to-severe pemphigus patients in the pandemic era: A single-center retrospective study
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Dermatologica Sinica (2024) Vol. 42, Iss. 1, pp. 31-38
Open Access | Times Cited: 2
Ceylan Avcı, Gülfem Akın, Sevgi Akarsu, et al.
Dermatologica Sinica (2024) Vol. 42, Iss. 1, pp. 31-38
Open Access | Times Cited: 2
COVID-19 Outcomes in Patients with Autoimmune Bullous Dermatoses: A Comparative Study of Pemphigus Vulgaris and Bullous Pemphigoid
Maryam Sadat Sadati, Marzieh Alizadeh, Fardin Karbakhsh Ravari, et al.
Research Square (Research Square) (2024)
Open Access
Maryam Sadat Sadati, Marzieh Alizadeh, Fardin Karbakhsh Ravari, et al.
Research Square (Research Square) (2024)
Open Access
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
Zane Lucāne, Baiba Šlisere, Gita Gersone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 1
Zane Lucāne, Baiba Šlisere, Gita Gersone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 1
Gaining perspective on messenger RNA coronavirus disease 2019 vaccination risk
Warren R. Heymann
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 3, pp. 476-477
Open Access
Warren R. Heymann
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 3, pp. 476-477
Open Access
